|
Pons-Fuster E, Martinez-Rodriguez R, Gimeno-Arias L, Alcaraz MJ, Moreno M, Gomez JM, Pelaez A, Garcia E, Tomas C, Munoz A, Martinez-Sanchez MV, Ruiz-Lorente I, Ceballos D, Minguela A, Bernal E. HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infect Dis Now. 2025 Mar 17:105057. doi: 10.1016/j.idnow.2025.105057. Online ahead of print. PubMed PMID: 40107360.
AÑO: 2025; IF: 2.2
|
40107360
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Cubillana PL, Aparicio TF, Egea LJA, Aviles JM, Iniguez GD, Martinez-Valls PLG, Server G, Ferri B, Campillo JA, Galindo F, Martinez-Sanchez MV, Minguela A. HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. Oncoimmunology. 2025 Dec 31;14(1):2598920. doi: 10.1080/2162402X.2025.2598920. Epub 2025 Dec 12. PubMed PMID: 41384865; PubMed Central PMCID: PMC12710922.
AÑO: 2025; IF: 6.3
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Jesus Asensio Egea L, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Galindo F, Boix F, Martinez-Sanchez MV, Martinez-Hernandez MD, Minguela A. Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer. Front Cell Dev Biol. 2025 Sep 4;13:1632101. doi: 10.3389/fcell.2025.1632101. eCollection 2025. PubMed PMID: 40977889; PubMed Central PMCID: PMC12443833.
AÑO: 2025; IF: 4.3
|